Assessment of medication adherence in patients with schizophrenia: the Achilles heel of adherence research

The Journal of Nervous and Mental Disease
Martijn J KikkertAart H Schene

Abstract

Measuring medication adherence in patients with schizophrenia is difficult and lacks a gold standard. Consequently, a great number of different methods and instruments have been proposed. Although it has been assumed that they all measure medication adherence, this study demonstrates that instruments differ significantly. Using data from an international multisite study (N = 329), we found that 3 questionnaires, designed to measure medication adherence and typical for instruments used in studies in patients with schizophrenia, do not agree in labeling patients as nonadherent. Further, they seem not to measure the same trait, are related to different established risk factors of nonadherence, and are only weakly related to these established risk factors of nonadherence. If these results are representative of the validity of other measures used in adherence research, this may have serious consequences for the interpretation of, and explanations for discrepancies found in the literature. Researchers should be aware of this problem and continue to combine objective and subjective methods in the hope of increasing the reliability and validity of measures of adherence.

References

Mar 1, 1992·Schizophrenia Research·D AddingtonJ Joyce
Jun 1, 1990·Archives of General Psychiatry·J K WingN Sartorius
Jun 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·A S David
Mar 1, 1984·The British Journal of Medical Psychology·D W Chan
Jan 1, 1995·Schizophrenia Bulletin·P J Weiden, M Olfson
May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·J C DayR P Bentall
May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·S H JonesG Dunn
Sep 1, 1993·The Journal of Nervous and Mental Disease·S G Adams, J T Howe
Oct 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·R Kemp, A David
Jan 1, 1997·Schizophrenia Bulletin·W S FentonR K Heinssen
Feb 19, 1998·Schizophrenia Research·J L Ayuso-Gutiérrez, J M del Río Vega
May 9, 1998·Psychiatric Services : a Journal of the American Psychiatric Association·J A Cramer, R Rosenheck
Sep 25, 1998·The British Journal of Psychiatry : the Journal of Mental Science·R KempA David
Dec 16, 1998·Schizophrenia Bulletin·A H ScheneM W Koeter
Jun 16, 1999·The Annals of Pharmacotherapy·M B NicholJ C Sung
Feb 11, 2000·Clinical Pharmacology and Therapeutics·I Arnet, W E Haefeli
Mar 8, 2000·Acta Psychiatrica Scandinavica·J Adams, J Scott
Aug 10, 2000·British Journal of Clinical Pharmacology·C F GeorgeC Thompson
Mar 23, 2001·Acta Psychiatrica Scandinavica. Supplementum·M OehlW W Fleischhacker
Jan 15, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael RitsnerIlan Modai
Jun 25, 2002·Issues in Mental Health Nursing·Jaya PinikahanaNicholas A Keks
Jan 14, 2003·The Journal of Clinical Psychiatry·Diana O Perkins
Nov 18, 2003·Acta Psychiatrica Scandinavica·S H MutsatsaT R E Barnes
Jun 2, 2004·Pharmacoepidemiology and Drug Safety·C A W RijckenL T W de Jong-van den Berg
Jul 9, 2004·The Annals of Pharmacotherapy·Stephen J ShalanskyAndrew P Ignaszewski
Jan 8, 2005·Acta Psychiatrica Scandinavica·A ZeeckT Herzog
Apr 12, 2005·Schizophrenia Research·Mirella RuggeriUNKNOWN EPSILON Study Group
May 10, 2005·Acta Psychiatrica Scandinavica. Supplementum·S R Marder
Jun 10, 2005·Acta Psychiatrica Scandinavica. Supplementum·D NaberM Lambert
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Nov 1, 2005·The American Journal of Geriatric Pharmacotherapy·Mary T Roth, Jena L Ivey
Mar 15, 2006·Schizophrenia Research·Diana O PerkinsUNKNOWN HGDH Research Group
May 19, 2006·Schizophrenia Bulletin·Dawn I VelliganAlexander L Miller
Aug 5, 2006·Schizophrenia Bulletin·Martijn J KikkertRichard J Gray
Dec 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Richard GrayMichele Tansella

❮ Previous
Next ❯

Citations

May 21, 2010·Journal of Psychiatric Practice·Carol D ClaytonJean-Pierre Lindenmayer
Oct 16, 2013·Journal of Clinical Psychopharmacology·Johan ReutforsRobert Bodén
Feb 5, 2013·Patient Preference and Adherence·Jose Manuel MontesEsteban Medina
Dec 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·A B P StaringC L Mulder
Jul 30, 2014·International Journal of Mental Health Nursing·Mitchell K ByrneElizabeth Connaughton
Oct 4, 2014·International Journal of Mental Health Nursing·Anna Hegedüs, Bernd Kozel
May 11, 2011·International Journal of Methods in Psychiatric Research·Martijn J KikkertAart H Schene
Feb 28, 2015·Journal of Psychiatric and Mental Health Nursing·R Gray
Aug 13, 2011·Nordic Journal of Psychiatry·David MisdrahiPierre-Michel Llorca
Jun 10, 2009·Journal of Psychiatric Research·Rebecca Schennach-WolffMichael Riedel
Mar 23, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·E ShemeshB L Shneider
Nov 1, 2013·World Journal of Psychiatry·Francisco Javier AcostaCarlos J Rodríguez
Dec 19, 2017·The Journal of Nervous and Mental Disease·Jeffrey M PyneRichard Owen
Jul 1, 2010·Expert Opinion on Pharmacotherapy·Ofer AgidGary Remington
Jan 26, 2011·Epidemiologia e psichiatria sociale·Johanna MeierBernd Puschner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.